Search research articles
Contact Us
Filters
Showing results (1001-1010 of 1,893) with videos related to
Page
of 190
Sort By:
Journal of Clinical Microbiology
|
February 7, 2001
Agilent 2100 bioanalyzer for restriction fragment length polymorphism analysis of the Campylobacter jejuni flagellin gene
I Nachamkin, N J Panaro, M Li, et al.
Diabetes Research and Clinical Practice
|
November 5, 2018
A phase 3 randomized placebo-controlled trial to assess the efficacy and safety of ipragliflozin as an add-on therapy to metformin in Russian patients with inadequately controlled type 2 diabetes mellitus
Marina V Shestakova, John P H Wilding, Wim Wilpshaar, et al.
Cancer Research
|
February 15, 1991
Phase I clinical trial of fazarabine as a twenty-four-hour continuous infusion
H Bailey, K D Tutsch, R Z Arzoomanian, et al.
Frontiers in Immunology
|
April 27, 2019
Biomarkers in Human Anaphylaxis: A Critical Appraisal of Current Evidence and Perspectives
Sarah C Beck, Thomas Wilding, Richard J Buka, et al.
Drug and Alcohol Dependence
|
April 29, 2023
Development and psychometric properties of the Multidimensional Inventory of Recovery Capital (MIRC)
Elizabeth Bowen, Andrew Irish, Gregory Wilding, et al.
Toxins
|
September 12, 2020
Is a Central Sediment Sample Sufficient? Exploring Spatial and Temporal Microbial Diversity in a Small Lake
Barbara Weisbrod, Susanna A Wood, Konstanze Steiner, et al.
The Journal of Chemical Physics
|
May 17, 2018
Composition inversion in mixtures of binary colloids and polymer
Isla Zhang, Rattachai Pinchaipat, Nigel B Wilding, et al.
Chemical Science
|
May 19, 2023
Synthesis of biolabile thioalkyl-protected phosphates from an easily accessible phosphotriester precursor
Lloyd D Murphy, Kathryn E Huxley, Ava Wilding, et al.
Clinical Genitourinary Cancer
|
August 15, 2015
Atrasentan in Patients With Advanced Renal Cell Carcinoma: A Phase 2 Trial of the ECOG-ACRIN Cancer Research Group (E6800)
Michael A Carducci, Judith Manola, Suresh G Nair, et al.
Genes & Cancer
|
December 2, 2015
Inhibitor of p52 NF-κB subunit and androgen receptor (AR) interaction reduces growth of human prostate cancer cells by abrogating nuclear translocation of p52 and phosphorylated AR(ser81)
Farideh Mehraein-Ghomi, Dawn R Church, Cynthia L Schreiber, et al.
Page
of 190
Search research articles
Search
Showing results (1001-1010 of 1,893) with videos related to
Sort By:
Page
of 190
Journal of Clinical Microbiology
|
February 7, 2001
Agilent 2100 bioanalyzer for restriction fragment length polymorphism analysis of the Campylobacter jejuni flagellin gene
I Nachamkin, N J Panaro, M Li, et al.
Diabetes Research and Clinical Practice
|
November 5, 2018
A phase 3 randomized placebo-controlled trial to assess the efficacy and safety of ipragliflozin as an add-on therapy to metformin in Russian patients with inadequately controlled type 2 diabetes mellitus
Marina V Shestakova, John P H Wilding, Wim Wilpshaar, et al.
Cancer Research
|
February 15, 1991
Phase I clinical trial of fazarabine as a twenty-four-hour continuous infusion
H Bailey, K D Tutsch, R Z Arzoomanian, et al.
Frontiers in Immunology
|
April 27, 2019
Biomarkers in Human Anaphylaxis: A Critical Appraisal of Current Evidence and Perspectives
Sarah C Beck, Thomas Wilding, Richard J Buka, et al.
Drug and Alcohol Dependence
|
April 29, 2023
Development and psychometric properties of the Multidimensional Inventory of Recovery Capital (MIRC)
Elizabeth Bowen, Andrew Irish, Gregory Wilding, et al.
Toxins
|
September 12, 2020
Is a Central Sediment Sample Sufficient? Exploring Spatial and Temporal Microbial Diversity in a Small Lake
Barbara Weisbrod, Susanna A Wood, Konstanze Steiner, et al.
The Journal of Chemical Physics
|
May 17, 2018
Composition inversion in mixtures of binary colloids and polymer
Isla Zhang, Rattachai Pinchaipat, Nigel B Wilding, et al.
Chemical Science
|
May 19, 2023
Synthesis of biolabile thioalkyl-protected phosphates from an easily accessible phosphotriester precursor
Lloyd D Murphy, Kathryn E Huxley, Ava Wilding, et al.
Clinical Genitourinary Cancer
|
August 15, 2015
Atrasentan in Patients With Advanced Renal Cell Carcinoma: A Phase 2 Trial of the ECOG-ACRIN Cancer Research Group (E6800)
Michael A Carducci, Judith Manola, Suresh G Nair, et al.
Genes & Cancer
|
December 2, 2015
Inhibitor of p52 NF-κB subunit and androgen receptor (AR) interaction reduces growth of human prostate cancer cells by abrogating nuclear translocation of p52 and phosphorylated AR(ser81)
Farideh Mehraein-Ghomi, Dawn R Church, Cynthia L Schreiber, et al.
Page
of 190